The Game Has Changed: Why FDA’s New Risk-Based Inspection Process Demands a Different Kind of Consultant

February 2, 2026: FDA’s new inspection manual made checklist inspections obsolete overnight. Now investigators follow risk through interconnected processes—and if your QMS can’t demonstrate bidirectional traceability in real-time, you’re not ready.